2024 annual financial data
Novavax 2024 Operating margin
Direct answer
Operating margin was -36.49%.
Operating income was -248,931,000 USD and net income was -187,499,000 USD.
Operating cash flow was -87,263,000 USD.
Get free Novavax email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 682,162,000 USD
- Operating income
- -248,931,000 USD
- Net income
- -187,499,000 USD
- Operating cash flow
- -87,263,000 USD